Self-reported habitual short sleep duration is associated with endothelial fibrinolytic dysfunction in men: A preliminary report

Sleep

Volumn 36, Issue 2, 2013, Pages 183-188

  Weil, Brian R ^a   Greiner, Jared J ^a   Stauffer, Brian L ^a,b,c   DeSouza, Christopher A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Endothelial function; Fibrinolysis; Sleep; Tissue type plasminogen activator

Indexed keywords

BRADYKININ; NITROPRUSSIDE SODIUM; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CLINICAL ARTICLE; ENDOTHELIAL DYSFUNCTION; FEMALE; FIBRINOLYSIS; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; RISK ASSESSMENT; SELF REPORT; SLEEP TIME; THROMBOSIS;

ENDOTHELIUM, VASCULAR; HUMANS; MALE; MIDDLE AGED; SLEEP; SLEEP DISORDERS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84873340708     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2368     Document Type: Article

References (54)

1. Egan BM. Sleep and hypertension: burning the candle at both ends really is hazardous to your health. Hypertension 2006;47:816-7.
2. Sleep in America Poll. In. Washington: National Sleep Foundation, 2009.
3. Banks S, Dinges DF. Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med 2007;3:519-28.
4. Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003;163:205-9.
5. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 2006;47:833-9.
6. Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension: The Sleep Heart Health Study. Sleep 2006;29:1009-14.
7. Qureshi AI, Giles WH, Croft JB, Bliwise DL. Habitual sleep patterns and risk for stroke and coronary heart disease: A 10-year follow-up from NHANES I. Neurology 1997;48:904-11.
8. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: A systematic review and metaanalysis of prospective studies. Eur Heart J 2011;32:1484-92.
9. Weil BR, Mestek ML, Westby CM, et al. Short sleep duration is associated with enhanced endothelin-1 vasoconstrictor tone. Can J Physiol Pharmacol 2010;88:777-81.
10. Sauvet F, Leftheriotis G, Gomez-Merino D, et al. Effect of acute sleep deprivation on vascular function in healthy subjects. J Appl Physiol 2010;108:68-75.
11. Oliver JJ, Webb DJ, Newby DE. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol 2005;25:2470-9.
12. Lijnen HR, Collen D. Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis 1997;39:343-50.
13. Brommer EJ. The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards. Thromb Res 1984;34:109-15.
14. Fox KA, Robison AK, Knabb RM, Rosamond TL, Sobel BE, Bergmann SR. Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. Circulation 1985;72:1346-54.
15. Cushman M, Lemaitre RN, Kuller LH, et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:493-8.
16. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994;343:940-3.
17. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993;341:1165-8.
18. Robinson SD, Ludlam CA, Boon NA, Newby DE. Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2007;27:1651-6.
19. Miller MA, Kandala NB, Kumari M, Marmot MG, Cappuccio FP. Relationships between sleep duration and von Willebrand factor, factor VII, and fibrinogen: Whitehall II study. Arterioscler Thromb Vasc Biol 2010;30:2032-8.
20. von Kanel R, Loredo JS, Ancoli-Israel S, Mills PJ, Natarajan L, Dimsdale JE. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest 2007;131:733-9.
21. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985;121:91-106.
22. Weil BR, MacEneaney OJ, Stauffer BL, DeSouza CA. Habitual short sleep duration and circulating endothelial progenitor cells. J Cardiovasc Dis Res 2011;2:110-14.
23. Hall MH, Muldoon MF, Jennings JR, Buysse DJ, Flory JD, Manuck SB. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep 2008;31:635-43.
24. Knutson KL, Ryden AM, Mander BA, Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006;166:1768-74.
25. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004;1:e62.
26. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005;165:863-7.
27. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-6.
28. Patel SR, Ayas NT, Malhotra MR, et al. A prospective study of sleep duration and mortality risk in women. Sleep 2004;27:440-4.
29. Lohman TG, Roche AF, Mortorelli R. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics, 1988.
30. Van Guilder GP, Hoetzer GL, Smith DT, et al. Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise. Am J Physiol Endocrinol Metab 2005;289:E807-13.
31. Hoetzer GL, Stauffer BL, Irmiger HM, Ng M, Smith DT, DeSouza CA. Acute and chronic effects of oestrogen on endothelial tissue-type plasminogen activator release in postmenopausal women. J Physiol 2003;551:721-8.
32. Jern S, Wall U, Bergbrant A, Selin-Sjogren L, Jern C. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension. Arterioscler Thromb Vasc Biol 1997;17:3376-83.
33. Chaplin H Jr., Mollison PL. Correction for plasma trapped in the red cell column of the hematocrit. Blood 1952;7:1227-38.
34. Macko RF, Ameriso SF, Gruber A, et al. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke 1996;27:2005-11.
35. Sabanayagam C, Shankar A. Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep 2010;33:1037-42.
36. Smith DT, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans. J Physiol 2003;546(Pt 1):289-98.
37. Christie PD, Edelberg JM, Picard MH, et al. A murine model of myocardial microvascular thrombosis. J Clin Invest 1999;104:533-9.
38. Shigeta H, Shigeta M, Nakazawa A, Nakamura N, Yoshikawa T. Lifestyle, obesity, and insulin resistance. Diabetes Care 2001;24:608.
39. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-9.
40. Vorona RD, Winn MP, Babineau TW, Eng BP, Feldman HR, Ware JC. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 2005;165:25-30.
41. Hayes AL, Xu F, Babineau D, Patel SR. Sleep duration and circulating adipokine levels. Sleep 2011;34:147-52.
42. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005;28:1289-96.
43. Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: The missing link in atherosclerosis? J Mol Med 2004;82:671-7.
44. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on Creactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004;43:678-83.
45. Vgontzas AN, Zoumakis E, Bixler EO, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004;89:2119-26.
46. Devaraj S, Singh U, Jialal I. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 2009;55:229-38.
47. Singh U, Devaraj S, Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 2005;25:2216-21.
48. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Acute and chronic effects of vitamin C on endothelial fibrinolytic function in overweight and obese adult humans. J Physiol 2008;586:3525-35.
49. Miskin R, Abramovitz R. Enhancement of PAI-1 mRNA in cardiovascular cells after kainate injection is mediated through the sympathetic nervous system. J Mol Cell Cardiol 2005;38:715-22.
50. Nagai M, Hoshide S, Kario K. Sleep duration as a risk factor for cardiovascular disease-A review of the recent literature. Curr Cardiol Rev 2010;6:54-61.
51. Zhong X, Hilton HJ, Gates GJ, et al. Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol 2005;98:2024-32.
52. Lockley SW, Skene DJ, Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 1999;8:175-83.
53. Hauri PJ, Wisbey J. Wrist actigraphy in insomnia. Sleep 1992;15:293-301.
54. Stauffer BL, Hoetzer GL, Van Guilder GP, Smith DT, Desouza CA. Gender differences in endothelial tissue-type plasminogen activator release in middle-aged adults. J Am Coll Cardiol 2005;45:1547-9.